OEP Group owned high-end and advanced equipment to fulfill the requirement to produce capsules, tablets and nano-injections as well as can meet the quantity needs from small batch to commercial production. The multi-year experience team provides a full range of collaborative projects and equips with the exclusive technology platform for jointly developing new drugs.
Cooperation projects and needs
1. Out-licensing Product: NDA-Methydur,new combination oral solution for sialorrhea,new medical efficacy tab for tuberculosis,botanical drug for NSCLC
2. Out-licensing Product: ANDA-Pitavastatin tab, Miglitol tab, Carisoprodol tab, Glyburide+Metformin tab, Glyburide, Erdosteine cap, Vancomycin cap..etc.
3. Contract development: formulation/process development and improvement of tab/cap. Contract manufacturing: tab/cap, cytotoxic anticancer injections